OTLK Company Profile and Key Details

Outlook Therapeutics, Inc. (NASDAQ: OTLK) stock price is $2.02 in the last trading session. During the trading session, OTLK stock reached the peak price of $2.03 while $1.97 was the lowest point it dropped to. The percentage change in OTLK stock occurred in the recent session was 1.51% while the dollar amount for the price change in OTLK stock was $0.03.

The NASDAQ listed OTLK is part of Biotechnology industry that operates in the broader Healthcare sector. Outlook Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Rick Gregory
Director of Marketing & Communications
Mr. C. Russell Trenary III
Pres, Chief Executive Officer & Director
Mr. Lawrence A. Kenyon CPA
Executive Vice President, Chief Financial Officer, Treasurer, Company Sec. & Director
Mr. Terry Dagnon
Chief Operations Officer
Ms. Elizabeth A. Yamashita
Advisor
Ms. Alicia Tozier
Senior Vice President, Marketing & Market Access
Dr. Surendra Sharma M.D.
Senior Vice President of Medical Affairs
Mr. Jeffrey Evanson
Chief Commercial Officer
Mr. Ralph H. Thurman
Independent Executive Chairman
Mr. Joel Prieve
Senior Vice President of Commercial Operations

OTLK's closing price is 132.18% higher than its 52-week low of $0.87 where as its distance from 52-week high of $12.85 is -84.28%.

Number of OTLK employees currently stands at 24.

Official Website of OTLK is: https://www.outlooktherapeutics.com

OTLK could be contacted at phone 609 619 3990 and can also be accessed through its website. OTLK operates from Building F, Iselin, NJ 08852, United States.

OTLK stock volume for the day was 446.86K shares. The average number of OTLK shares traded daily for last 3 months was 2.08M.

The market value of OTLK currently stands at $64.60M with its latest stock price at $2.02 and 31.98M of its shares outstanding.